• Home

• Small Molecules: Hit identification

• Small Molecules: Hit-to-Lead optimization

• Small Molecules: physicochemical properties

• Small Molecules: ADME

• Small Molecules: Toxicity

• Small Molecules: Selectivity

• Antibodies: Humanization and Optimization

• Protein Modeling. Discovery

• Protein Modeling: HERG binding

• Protein Modeling: Albumin binding

• Quantum Discussions Forum    

You access the old version of our website. Please point your browser to our new home page.

Research organizations

Quantum Pharmaceuticals proposes cooperation in the field of drug discovery with scientific-research organizations on the following principles:

Quantum Pharmaceuticals and the organization will unite their research and technological potentials for the creation of new medical remedies. The possibility exists for Quantum Pharmaceuticals to finance joint projects. Quantum Pharmaceuticals and the organization collaborate on marketing and sales of the results of the joint research process. The proceeds from sales of the new drug will be shared by the organization and Quantum Pharmaceuticals in accordance with their preexisting agreements.

The Organization's Role in the Research Process:

The organization will provide research into the biochemical pathways in the development of a disease and its biological markers—proteins whose biological function it is necessary to block in order to have a therapeutic effect and consequent perspectives for the creation of a new drug.

Quantum Pharmaceuticals’ Research and Development Process:

Quantum Pharmaceuticals will use its technological and financial resources for the creation of these new drugs. Quantum Pharmaceuticals will provide modeling of the molecules and optimization of their pharmacodynamic and pharmacokinetic properties. In the event of positive results, the entity will be patented

Marketing:

After the receipt of a patent, the organization and Quantum Pharmaceuticals will make one of the following decisions:

1.Sale of the patent rights to one of the large pharmaceutical companies for further study.

2.Carrying out of preclinical and clinical trials with the subsequent sales rights on the product.

3.Taking the new drug to the certification stage and the sale of the drug on the consumer market.